These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 7841578)

  • 1. Gabapentin: a new agent for the management of epilepsy.
    Andrews CO; Fischer JH
    Ann Pharmacother; 1994 Oct; 28(10):1188-96. PubMed ID: 7841578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gabapentin in the management of convulsive disorders.
    McLean MJ
    Epilepsia; 1999; 40 Suppl 6():S39-50; discussion S73-4. PubMed ID: 10530682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy and safety of gabapentin.
    Ramsay RE
    Neurology; 1994 Jun; 44(6 Suppl 5):S23-30; discussion S31-2. PubMed ID: 8022537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
    French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; ;
    Epilepsia; 2004 May; 45(5):410-23. PubMed ID: 15101822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
    French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ;
    Neurology; 2004 Apr; 62(8):1252-60. PubMed ID: 15111659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gabapentin for drug-resistant partial epilepsy.
    Marson AG; Kadir ZA; Hutton JL; Chadwick DW
    Cochrane Database Syst Rev; 2000; (2):CD001415. PubMed ID: 10796785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gabapentin and lamotrigine: novel antiepileptic drugs.
    Btaiche IF; Woster PS
    Am J Health Syst Pharm; 1995 Jan; 52(1):61-9. PubMed ID: 12879525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gabapentin. A review of its pharmacological properties and clinical potential in epilepsy.
    Goa KL; Sorkin EM
    Drugs; 1993 Sep; 46(3):409-427. PubMed ID: 7693432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gabapentin.
    McLean MJ
    Epilepsia; 1995; 36 Suppl 2():S73-86. PubMed ID: 8784216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gabapentin add-on for drug-resistant partial epilepsy.
    Marson AG; Kadir ZA; Hutton JL; Chadwick DW
    Cochrane Database Syst Rev; 2000; (3):CD001415. PubMed ID: 10908495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gabapentin.
    Morris GL
    Epilepsia; 1999; 40 Suppl 5():S63-70. PubMed ID: 10530696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gabapentin: a unique anti-epileptic agent.
    Dougherty JA; Rhoney DH
    Neurol Res; 2001 Dec; 23(8):821-9. PubMed ID: 11760873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gabapentin dosing in the treatment of epilepsy.
    McLean MJ; Gidal BE
    Clin Ther; 2003 May; 25(5):1382-406. PubMed ID: 12867216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monotherapy trials with gabapentin for partial epilepsy.
    Beydoun A
    Epilepsia; 1999; 40 Suppl 6():S13-6; discussion S73-4. PubMed ID: 10530677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gabapentin.
    Bruni J
    Can J Neurol Sci; 1996 Nov; 23(4 Suppl 2):S10-2. PubMed ID: 8951214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of gabapentin.
    McLean MJ
    Neurology; 1994 Jun; 44(6 Suppl 5):S17-22; discussion S31-2. PubMed ID: 8022536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenobarbitone to gabapentin: a guide to 82 years of anti-epileptic drug pharmacokinetic interactions.
    Patsalos PN
    Seizure; 1994 Sep; 3(3):163-70. PubMed ID: 8000709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
    French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; ;
    Epilepsia; 2004 May; 45(5):401-9. PubMed ID: 15101821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gabapentin (NEURONTIN)--a novel anticonvulsant.
    Murdoch LA
    Axone; 1994 Dec; 16(2):56. PubMed ID: 7727298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. The US Gabapentin Study Group No. 5.
    Neurology; 1993 Nov; 43(11):2292-8. PubMed ID: 8232945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.